RxDoctor Payments DataLook up a doctor →

Ira Goodman

Neurological Surgery · Orlando, FLNPI 1841260734

Payments from drug & device makers

$10,402,347in general payments, 2019–2025

Across 627 payments — averaging $16,591 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2.8M
  • Genentech, Inc.$2.4M
  • Eli Lilly$2.1M
  • Novartis$1.2M
  • Sunovion Pharmaceuticals Inc.$759K
  • Roche TCRC, Inc.$380K
  • plus $782K from 12 others
$49,777in research payments, 2019–2025

Across 12 payments — averaging $4148.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$50K

What the payments were for

  • Consulting fees$12,71410%
  • Speaking & faculty fees$105,07585%
  • Travel & lodging$2,7762%
  • Food & beverage$2,5492%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,402,347 in reported general payments places this provider in the 95th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida

Other neurological surgery in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →